Hoffman Robert E. bought ESPR
May 28, 2026 · Form 4 insider transaction
Hoffman Robert E. bought 79,873 shares of Esperion Therapeutics, Inc. Common Stock at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
79,873
Price
$0.00
Total value
N/A
InsiderHoffman Robert E.
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMay 28, 2026
Filing dateJune 1, 2026
Shares owned after85,153
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The awards vest in full on the earlier of (i) May 28, 2027 and (ii) the Issuer's next annual meeting of stockholders following May 28, 2026.